# Bisoprolol

## CONCOR 5mg

##### 

| 藥品代碼   | OCON                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | 1.25 mg & 2.5 mg tab Stable chronic moderate to severe heart failure. 5 mg & 10 mg tab Management of hypertension， angina pectoris & stable， chronic moderate to severe heart failure (NYHA class III， IV).                                                                                                                                                                                                                                                                                                  |
| 用法用量   | Hypertension， angina: Initially 5mg QD， may up to 10mg QD if needed. Maximum: 20mg QD. Stable mild to server chronic heart failure: Patient must be treated at an optimal dose with an ACE inhibitor， a diuretic， & optionally cardiac glycosides， prior to the administration of bisoprolol. Titrate gradually as follows: Week 1: 1.25 mg QD. Week 2: 2.5 mg QD. Week 3: 3.75 mg QD. Week 4-7: 5 mg QD. Week 8-11: 7.5 mg QD. Week 12 and beyond: 10 mg QD as maintenance therapy. Maximum: 10 mg daily. |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 禁忌       | Acute heart failure or during episodes of heart failure decompensation requiring IV inotropic therapy， cardiogenic shock， AV block of grades II & III (without pacemaker)， sick sinus syndrome， SA block， bradycardia with < 60 beats/min; severe bronchial asthma or severe COPD， hypotension (systolic BP < 100 mmHg)， advanced stages of peripheral arterial circulatory disturbance & Raynaud's syndrome， untreated pheochromocytoma， metabolic acidosis.                                          |
| 副作用     | Feeling of coldness or numbness in the extremities， nausea， vomiting， diarrhea， constipation. Tiredness， exhaustion， dizziness， headache (occur at the beginning of the therapy & usually disappear within 1-2 weeks). Gastrointestinal: Diarrhea (2.6% to 3.5% ) Neurologic: Headache (8.8% to 10.9% ) Respiratory: Rhinitis (2.9% to 4% )， Upper respiratory infection (4.8% to 5% .) Other: Fatigue (6.6% to 8.2%)                                                                                   |
| 孕期建議   | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                            |

## Concor 1.25mg康肯錠

##### 

| 藥品代碼   | OCON1                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | 1.25 mg & 2.5 mg tab Stable chronic moderate to severe heart failure. 5 mg & 10 mg tab Management of hypertension， angina pectoris & stable， chronic moderate to severe heart failure (NYHA class III， IV).                                                                                                                                                                                                                                                         |
| 用法用量   | Stable mild to server chronic heart failure: Patient must be treated at optimal dose with an ACE inhibitor， a diuretic， & optionally cardiac glycosides， prior to the administration of bisoprolol. Titrate gradually as follows: Week 1: 1.25 mg QD. Week 2: 2.5 mg QD. Week 3: 3.75 mg QD. Week 4-7: 5 mg QD. Week 8-11: 7.5 mg QD. Week 12 and beyond: 10 mg QD as maintenance therapy. Maximum: 10 mg daily.                                                    |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌       | Acute heart failure or during episodes of heart failure decompensation requiring IV inotropic therapy， cardiogenic shock， AV block of grades II & III (without pacemaker)， sick sinus syndrome， SA block， bradycardia with < 60 beats/min; severe bronchial asthma or severe COPD， hypotension (systolic BP < 100 mmHg)， advanced stages of peripheral arterial circulatory disturbance & Raynaud's syndrome， untreated pheochromocytoma， metabolic acidosis. |
| 副作用     | Feeling of coldness or numbness in the extremities， nausea， vomiting， diarrhea， constipation. Tiredness， exhaustion， dizziness， headache (occur at the beginning of the therapy & usually disappear within 1-2 weeks). Gastrointestinal: Diarrhea (2.6% to 3.5% ) Neurologic: Headache (8.8% to 10.9% ) Respiratory: Rhinitis (2.9% to 4% )， Upper respiratory infection (4.8% to 5% .) Other: Fatigue (6.6% to 8.2%)                                          |
| 孕期建議   | Human data suggest risk in 2nd and 3 rd trimesters                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 哺乳期建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                   |

